Postmenopausal Breast Cancer Patients on Aromatase Inhibitor Therapy and Their Increased Risk of Fragility Fracture

被引：0
|
作者：
Lafian, Anna [1 ]
Suh, Julia [2 ]
Torralba, Karina [3 ]
机构：
[1] Arrowhead Reg Med Ctr, Internal Med, Colton, CA USA
[2] Loma Linda Univ, Internal Med, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Internal Med Rheumatol, Loma Linda, CA 92350 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1228
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
  • [2] Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (03): : 217 - 217
  • [3] Acupuncture for the treatment of arthralgia related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients
    Barzaghi, S.
    Gozzo, S.
    Giardina, G.
    Bascialla, L.
    Gueli, R.
    Marcon, I.
    Vallini, I.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 24 - 25
  • [4] Personalizing aromatase inhibitor therapy in patients with breast cancer
    Hamadeh, Issam S.
    Patel, Jai N.
    Rusin, Stephanie
    Tan, Antoinette R.
    [J]. CANCER TREATMENT REVIEWS, 2018, 70 : 47 - 55
  • [5] Perioperative Aromatase Inhibitor Therapy for Patients with Breast Cancer
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (02) : 114 - +
  • [6] Fragility Fracture Risk Reduction in Women with Breast Cancer on Aromatase Inhibitors Treated with Anti-Osteoporosis Therapy
    Cheng, Yu-Chien
    Bullock, Cydney
    Gandhi, Shriya
    Sterenstein, Andrea
    Randall, Megan
    Ahmad, Sara
    Thakkar, Samarthkumar
    Morkos, Michael
    Meier, Garnet
    Baim, Sanford
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 317 - 317
  • [7] Sexual Dysfunction in Postmenopausal Women with Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Lubian Lopez, Daniel Maria
    Butron Hinojo, Carmen Aisha
    Sanchez-Prieto, Manuel
    Mendoza, Nicolas
    Sanchez-Borrego, Rafael
    [J]. BREAST CARE, 2021, 16 (04) : 376 - 382
  • [8] Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
    Chen, Han
    Shao, Zhi-Ming
    Yu, Ke-Da
    Xu, Ge-Zhi
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [9] Which is the best aromatase inhibitor for postmenopausal breast cancer?
    [J]. Drugs & Therapy Perspectives, 2000, 16 (8) : 5 - 7
  • [10] Interaction of fracture risk in an aromatase inhibitor therapy with other fracture risk
    不详
    [J]. OSTEOLOGIE, 2009, 18 (04) : 331 - 331
12345